PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsReducing levels of anti-implantation molecule increases IVF success

BioNews

Reducing levels of anti-implantation molecule increases IVF success

Published 27 August 2021 posted in News and appears in BioNews 1110

Author

Javier Bautista

PET BioNews

Screening for a molecule that inhibits embryo implantation, and timing embryo transfer around this, could improve IVF success rates...

Screening for a molecule that inhibits embryo implantation, and timing embryo transfer around this, could improve IVF success rates.

Researchers from RMIT University and Monash IVF in Australia have identified a molecule called podocalyxin (PCX) that makes the lining of the womb resistant to the implantation of the embryo. Levels of this molecule decrease at a certain point during the menstrual cycle, allowing the womb to become 'sticky' and increasing the likelihood of embryo implantation and pregnancy success. Women with low levels of PCX were found to have 53 percent pregnancy success rate following IVF, whereas those with high levels of PCX had an 18 percent pregnancy success rate, the results of a study published in the journal Fertility and Sterility showed.

'We've been looking for something that helps embryos stick when the vital part of the puzzle turned out to be a slippery molecule that has the opposite effect – it prevents them from sticking,' said senior author Professor Guiying Nie of Monash University in Melbourne, Australia.

The team originally identified PCX as an anti-implantation regulator of the embryo in cells isolated from the human endometrial tissue, and announced these results in a paper published in Human Reproduction.

In a subsequent clinical study, the same team examined the levels of PCX in endometrial tissue biopsies collected from 81 patients undergoing IVF. The biopsy of the uterus was performed at the mid-luteal phase (three to five days after ovulation) of the women's menstrual cycle, one full cycle before the transfer of the frozen embryo. The women who had lower levels of PCX detected in their biopsies had a higher pregnancy rate following IVF, than the women who had high levels of the molecule.

A limitation of the finding is that there is no way to screen the endometrial tissue biopsies for PCX levels on the day embryo transfer is due to take place. The research team's future goal is to develop non-invasive and real-time approaches for measuring PCX on the day of embryo transfer. This could eventually be used to optimise timing of embryo transfer to improve IVF success rates, and target PCX levels as a potential cause of infertility.

'We hope with further development our discovery could help clinicians identify precisely when each patient has the greatest chance of achieving pregnancy, delivering fully personalised IVF treatment,' said Professor Nie.

A patent application has been filed for the technology, with the hope future developments could help raise IVF success rates, which currently stand at less than 50 percent.

Sources and References

  • 13/07/2021
    Fertility and Sterility
    Podocalyxin inhibits human embryo implantation in vitro and luminal podocalyxin in putative receptive endometrium is associated with implantation failure in fertility treatment
  • 02/04/2021
    Human Reproduction
    Podocalyxin is a key negative regulator of human endometrial epithelial receptivity for embryo implantation
  • 23/08/2021
    RMIT University
    New discovery pinpoints the 'golden window' for IVF success
  • 25/08/2021
    Hospital Healthcare
    Slippery womb molecule could hold key to IVF 'golden window'
  • 23/08/2021
    7news
    Australian scientists identify IVF 'golden window' when womb is ready for pregnancy

Related Articles

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
18 July 2022 • 2 minutes read

Microscopic structures in semen could affect implantation

by Joseph Hawkins

Microscopic sacs, known as exosomes, present in semen may shed light on previously unexplained cases of male infertility...

PET BioNews
News
17 September 2021 • 2 minutes read

Preimplantation signalling system discovered in human embryos

by Laxmee Ramkhelawon

Human embryos can show an innate immune response when exposed to pathogens, as early as day five, researchers in the UK have found...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
3 September 2021 • 3 minutes read

Apps for patients undergoing fertility treatment promoted with unsupported claims

by Professor Ying Cheong and 1 others

There is currently a proliferation of mobile health apps in the women's health and fertility sectors…

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
26 July 2021 • 4 minutes read

IVF add-ons: are they supported by evidence?

by Sarah Lensen

IVF add-ons are procedures, techniques or medicines which can be used in addition to standard IVF protocols. They are usually offered by IVF clinics, and used by patients, with the hope that they will improve the chance of IVF success...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
8 July 2020 • 2 minutes read

Endometrial scratch has no effect on live birth rate for first time IVF patients

by Catherine Hill

Endometrial scratch, an IVF add-on treatment, has no effect on live birth rate for women undergoing a first IVF or ICSI cycle, study shows...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
5 July 2019 • 2 minutes read

Get A Drip withdraws unproven 'fertility IV'

by Rikita Patel

Wellness company Get A Drip has taken its 'fertility IV' drip off the market after the British Pregnancy Advisory Service (BPAS) said there was no evidence its treatment could improve fertility...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
2 July 2018 • 2 minutes read

Womb scratching: common IVF add-on has no benefit

by Shaoni Bhattacharya

A common procedure, known as endometrial or womb 'scratching', as an add-on to IVF has been shown to have no effect on pregnancy or birth rates...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Endometriosis-associated gene identified as a potential drug target

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856